Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEurocell Regulatory News (ECEL)

Share Price Information for Eurocell (ECEL)

Share Price is delayed by 15 minutes
Get Live Data
109.00    -0.50 (-0.46%)
Bid:
109.50
Ask:
111.00
Spread: 1.50 (1.37%)
Market Cap: £107.42m
ECEL Live PriceLast checked at - London Stock Exchange

Intraday Eurocell Share Chart

Trading Update

11 Dec 2019 07:00

RNS Number : 4378W
Eurocell plc
11 December 2019
Β 

11 December 2019

Β 

EUROCELL PLC

(Symbol: ECEL)

Β 

Trading Update

Β 

Eurocell(1) provides this update for the 11 months to 30 November 2019.

Β 

Trading and Operational Performance

We have continued to take market share and deliver a good sales performance in the second half of the year, albeit against strong 2018 comparatives. Revenue for the 11 months to 30 November 2019 is up 7% on a like-for-like basis(2).

Β·; Profiles division - like-for-like growth of 5% includes good contributions from both existing and new accounts from across our fabricator base.

Β·; Building Plastics - like-for-like growth of 8% reflects the positive impact of better stock availability and our new management team driving improvements in operating standards.

Β 

Gross margin is ahead of last year, reflecting higher usage of recycled material and selling price increases implemented progressively across the business in the first half to recover cost inflation.

Β 

We continue to incur some operating inefficiencies. However, as previously announced, Mark Hemming joined the business as Chief Operating Officer in August. Mark has made an excellent start and is now leading our drive to improve operating efficiency, focused initially in the following areas:

Β·; The capex programme launched at the beginning of the year to improve manufacturing efficiency and increase co-extrusion and foam capacity by 30% and 15% respectively is now complete. All the new lines are fully operational and working well.

Β·; As described at the half year, we have suffered some delays with our project to expand recycling capacity at Ecoplas. However, the programme is now well advanced and performance is improving.

Β·; We have continued to incur additional warehousing and distribution costs, particularly through the peak period, including the impact of a change in transport provider in September when the previous contract expired. We are reviewing options to expand our warehousing capacity.

Β 

As previously reported, we have invested in a stock build programme to mitigate the possible impact of raw material supply interruption due to Brexit, and to increase stock holding at our branches. We have added approximately Β£5 million to finished goods for key product lines under the plan, which provides a good level of protection and much improved availability.

Β 

Taken together, these factors underpin our current expectations for full year earnings.

Β 

Notice of Results

We will announce our preliminary results for the year ending 31 December 2019 on 13 March 2020.

Β 

Β 

~~~~~~~~~~~~~~~~~~~~~~~

Β 

Β 

Notes:

(1) Eurocell plc is a market leading, vertically integrated UK manufacturer, recycler and distributor of innovative window, door and roofline PVC products.

(2) Like-for-like sales exclude acquisitions and branches opened in 2018/19.

Β 

Β 

Enquiries:

Eurocell plc

Mark Kelly, Chief Executive Officer

+44 (0) 1773 842 105

Β 

Michael Scott, Chief Financial Officer

+44 (0) 1773 842 140

Β 

Teneo

Ben Foster

+44 (0) 20 3603 5221

Β 

Camilla Cunningham

+44 (0) 20 3757 9235

Β 

eurocell@teneo.com

Β 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
TSTKMMMZFGGGLZZ
Date   Source Headline
11th Apr 20237:00 amRNSAnnual Financial Report
20th Mar 20237:00 amRNSInvestor Presentation
17th Mar 20237:00 amRNSDirector/PDMR Shareholding
16th Mar 20237:00 amRNSPreliminary results for the year ended 31 Dec 2022
7th Mar 20237:00 amRNSBlock listing Interim Review
3rd Feb 20237:00 amRNSNon-executive Directors' Share Purchase Plan
31st Jan 20237:00 amRNSHolding(s) in Company
26th Jan 20237:00 amRNSYear End Trading Update
6th Jan 20237:00 amRNSCEO Announces Intention to Retire in 2023
15th Nov 20227:04 amRNSHolding(s) in Company
14th Nov 20227:00 amRNSHolding(s) in Company
10th Nov 20224:00 pmRNSHolding(s) in Company
8th Nov 20223:59 pmRNSDirectorate Change
26th Oct 20227:00 amRNSHolding(s) in Company
7th Oct 20227:00 amRNSChanges to Board Committee memberships
5th Oct 20222:00 pmRNSHolding(s) in Company
3rd Oct 20227:00 amRNSTotal Voting Rights
5th Sep 20227:00 amRNSBlock listing Interim Review
5th Sep 20227:00 amRNSInvestor Presentation
1st Sep 20227:00 amRNSHalf-year Report
15th Aug 20223:00 pmRNSHolding(s) in Company
10th Aug 20223:45 pmRNSAppointment to the Audit & Risk Committee
13th Jul 20227:00 amRNSTrading Update
5th Jul 202212:25 pmRNSHolding(s) in Company
1st Jul 20227:00 amRNSTotal Voting Rights
22nd Jun 20227:00 amRNSDirector/PDMR Shareholding
21st Jun 202212:08 pmRNSDirectorate Change
25th May 20227:00 amRNSBlock Listing Application
16th May 20227:00 amRNSDirector/PDMR Shareholding
12th May 20224:00 pmRNSResult of AGM
12th May 20227:00 amRNSAGM Trading Update and Board Update
14th Apr 20224:00 pmRNSDirector/PDMR Shareholding
14th Apr 20224:00 pmRNSDirector/PDMR Shareholding
8th Apr 20227:00 amRNSAnnual Financial Report
21st Mar 20227:00 amRNSInvestor Presentation
18th Mar 20227:00 amRNSPreliminary results for the year ended 31 Dec 2021
17th Mar 20227:00 amRNSNotice of Results and Audiocast
15th Mar 20223:05 pmRNSTransaction in Own Shares
9th Mar 20225:00 pmRNSBlock listing Interim Review
16th Feb 20227:00 amRNSAppointment of Joint Corporate Broker
21st Jan 20227:00 amRNSYear End Trading Update
4th Jan 20227:00 amRNSTotal Voting Rights
1st Dec 20217:00 amRNSTotal Voting Rights
24th Nov 20217:00 amRNSTrading Update November 2021
1st Nov 20217:00 amRNSTotal Voting Rights
1st Oct 20217:00 amRNSTotal Voting Rights
7th Sep 20214:00 pmRNSInvestor Presentation
7th Sep 20211:38 pmRNSBlock listing Interim Review
3rd Sep 20217:00 amRNSHalf-year Report
1st Sep 20217:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.